Literature DB >> 17611730

[Modification of vascular risk factors by intervention on the primary care level. Results of the INVADE project].

C Schulze Horn1, K Sander, R Ilg, H Bickel, C Briesenick, D Sander.   

Abstract

BACKGROUND: The so-called INVADE project examines the efficacy of consistent diagnosis and treatment of cerebrovascular risk factors on the incidence of stroke.
METHODS: This analysis compares known cardiovascular risk factors (elevated blood pressure, dipositas, hyperlipidemia, diabetes mellitus, and smoking) and respective medication of 2930 patients with respect to cerebrovascular disease, peripheral arterial disease (PAD), and coronary heart disease (CHD) between baseline and follow-up examination after 2 years of intervention.
RESULTS: Using the ankle-brachial index (ABI), 381 patients (13%) with asymptomatic PAD were identified. Comparison between baseline and follow-up examination revealed significant reductions in the following risk factors. Cerebrovascular disease: elevated blood pressure -12.8%, dipositas -4.2%, and LDL -8.1%. For PAD the results were: elevated blood pressure -7.2%, smoking -1.2%, elevated cholesterol -6.4%, dipositas -3.2%, and LDL -7.4%. For CHD the results were: elevated blood pressure -11.3%, elevated cholesterol -13.0%, and LDL -14.9%.
CONCLUSION: By the use of ABI, previously undiagnosed asymptomatic PAD was identified in 13% of all patients. Two-year intervention on the primary care level yielded significant reduction of known vascular risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 17611730     DOI: 10.1007/s00115-007-2305-1

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  21 in total

1.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III.

Authors:  P Greenland; J Abrams; G P Aurigemma; M G Bond; L T Clark; M H Criqui; J R Crouse; L Friedman; V Fuster; D M Herrington; L H Kuller; P M Ridker; W C Roberts; W Stanford; N Stone; H J Swan; K A Taubert; L Wexler
Journal:  Circulation       Date:  2000-01-04       Impact factor: 29.690

2.  AHA Conference Proceedings. Prevention conference V: Beyond secondary prevention: Identifying the high-risk patient for primary prevention: executive summary. American Heart Association.

Authors:  S C Smith; P Greenland; S M Grundy
Journal:  Circulation       Date:  2000 Jan 4-11       Impact factor: 29.690

3.  Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study.

Authors:  Dirk Sander; Carla Schulze-Horn; Horst Bickel; Hans Gnahn; Eva Bartels; Bastian Conrad
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

4.  Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease.

Authors:  N Fiotti; C Giansante; E Ponte; C Delbello; S Calabrese; T Zacchi; A Dobrina; G Guarnieri
Journal:  Atherosclerosis       Date:  1999-07       Impact factor: 5.162

5.  Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

Review 6.  Epidemiology of peripheral arterial disease.

Authors:  C Diehm; S Kareem; H Lawall
Journal:  Vasa       Date:  2004-11       Impact factor: 1.961

Review 7.  The treatment potential in preventive cardiology.

Authors:  D Wood
Journal:  Atheroscler Suppl       Date:  2001-02       Impact factor: 3.235

8.  A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months.

Authors:  P L Kolominsky-Rabas; C Sarti; P U Heuschmann; C Graf; S Siemonsen; B Neundoerfer; A Katalinic; E Lang; K G Gassmann; T R von Stockert
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

9.  C-reactive protein and risk factors for peripheral vascular disease in subjects with Type 2 diabetes mellitus.

Authors:  H-I Yu; W H-H Sheu; Y-M Song; H-C Liu; W-J Lee; Y-T Chen
Journal:  Diabet Med       Date:  2004-04       Impact factor: 4.359

10.  The reliability of the ankle-brachial index in the Atherosclerosis Risk in Communities (ARIC) study and the NHLBI Family Heart Study (FHS).

Authors:  Beth D Weatherley; Lloyd E Chambless; Gerardo Heiss; Diane J Catellier; Curtis R Ellison
Journal:  BMC Cardiovasc Disord       Date:  2006-02-21       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.